Houlihan Lokey, Inc. logo HLI - Houlihan Lokey, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 9
HOLD 5
SELL 1
STRONG
SELL
0
| PRICE TARGET: $183.20 DETAILS
HIGH: $211.00
LOW: $161.00
MEDIAN: $187.00
CONSENSUS: $183.20
UPSIDE: 38.54%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Fair Value Moderate
Trading 17.0% below fair value
Current Price $132.24
Bear Case $111.50 15.7% downside ($111.50 - $132.24) / $132.24 = -15.7% ROTCE 20.0% → 2.86x TBV
Fair Value $159.29 20.5% upside ($159.29 - $132.24) / $132.24 = 20.5% ROTCE 25.0% → 4.00x TBV
Bull Case $207.08 56.6% upside ($207.08 - $132.24) / $132.24 = 56.6% ROTCE 30.0% → 4.00x TBV

Adjust Assumptions

57.3%
9.6%

Key Value Driver

ROTCE (57.3%) vs. cost of equity (9.6%)

Implied Market Multiple 12.3x

Plain-Language Summary

Our base-case estimate uses P/Tangible Book × ROE Quality. We then blend that result with the average analyst price target of $183.20 from 15 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $159.29 per share.

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Dividend-based valuation: $87.90 (42% below our primary estimate). Large gaps suggest the dividend may not fully reflect the company's value.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly